Concepedia

CA 19-9 and Survival in Advanced and Unresectable Pancreatic Adenocarcinoma and Cholangiocarcinoma

Clinton Ali, Thomas F. Kaye, Douglas Adamson, Iain S. Tait, Francesco M. Polignano, Martin Highley

Journal of Gastrointestinal Cancer · 2007 · 18 citations · 18 references

DOI

Concepts

References

18

Colorectal carcinoma antigens detected by hybridoma antibodies

Hilary Koprowski, Zenon Steplewski, Kenneth F. Mitchell et al. · Somatic Cell and Molecular Genetics · 1979 · 1.4K citations

, , +14

The clinical utility of the CA 19-9 tumor-associated antigen.

William M. Steinberg · PubMed · 1990 · 585 citations

, , +13

Perioperative CA19-9 Levels Can Predict Stage and Survival in Patients With Resectable Pancreatic Adenocarcinoma

Cristina R. Ferrone, Dianne M. Finkelstein, Sarah P. Thayer et al. · Journal of Clinical Oncology · 2006 · 549 citations · Full text

, , +17

Decrease of CA 19–9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer

U. Halm, Thomas L. Schumann, Ingolf Schiefke et al. · British Journal of Cancer · 2000 · 197 citations · Full text

, , +13

Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine

Carsten Ziske, Christin Schlie, Marcus Gorschlüter et al. · British Journal of Cancer · 2003 · 169 citations · Full text

, , +14